Published online Sep 7, 2018. doi: 10.5492/wjccm.v7.i4.46
Peer-review started: June 2, 2018
First decision: July 9, 2018
Revised: July 25, 2018
Accepted: August 4, 2018
Article in press: August 5, 2018
Published online: September 7, 2018
Processing time: 97 Days and 13.6 Hours
To characterize the clinical course and outcomes of nasal intermittent mandatory ventilation (NIMV) use in acute pediatric respiratory failure.
We identified all patients treated with NIMV in the pediatric intensive care unit (PICU) or inpatient general pediatrics between January 2013 and December 2015 at two academic centers. Patients who utilized NIMV with other modes of noninvasive ventilation during the same admission were included. Data included demographics, vital signs on admission and prior to initiation of NIMV, pediatric risk of mortality III (PRISM-III) scores, complications, respiratory support characteristics, PICU and hospital length of stays, duration of respiratory support, and complications. Patients who did not require escalation to mechanical ventilation were defined as NIMV responders; those who required escalation to mechanical ventilation (MV) were defined as NIMV non-responders. NIMV responders were compared to NIMV non-responders.
Forty-two patients met study criteria. Six (14%) failed treatment and required MV. The majority of the patients (74%) had a primary diagnosis of bronchiolitis. The median age of these 42 patients was 4 mo (range 0.5-28.1 mo, IQR 7, P = 0.69). No significant difference was measured in other baseline demographics and vitals on initiation of NIMV; these included age, temperature, respiratory rate, O2 saturation, heart rate, systolic blood pressure, diastolic blood pressure, and PRISM-III scores. The duration of NIMV was shorter in the NIMV non-responder vs NIMV responder group (6.5 h vs 65 h, P < 0.0005). Otherwise, NIMV failure was not associated with significant differences in PICU length of stay (LOS), hospital LOS, or total duration of respiratory support. No patients had aspiration pneumonia, pneumothorax, or skin breakdown.
Most of our patients responded to NIMV. NIMV failure is not associated with differences in hospital LOS, PICU LOS, or duration of respiratory support.
Core tip: In our cohort of patients between 0.5 and 28.1 mo of age with acute respiratory failure, the majority of patients were successfully supported with nasal intermittent mandatory ventilation (NIMV) alone or NIMV in conjunction with other modes of noninvasive ventilation (NIV). Use of NIMV with or without NIV was not associated with significant differences in hospital length of stay (LOS), pediatric intensive care unit LOS, or duration of respiratory support. Failure of NIMV with or without NIV was recognized in a median of 6.5 h.